These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28331354)

  • 1. Utilization and prescribing patterns of direct oral anticoagulants.
    Whitworth MM; Haase KK; Fike DS; Bharadwaj RM; Young RB; MacLaughlin EJ
    Int J Gen Med; 2017; 10():87-94. PubMed ID: 28331354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate Prescribing.
    Moudallel S; Steurbaut S; Cornu P; Dupont A
    Front Pharmacol; 2018; 9():1220. PubMed ID: 30425641
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions.
    Zhang ZX; van de Garde EMW; Söhne M; Harmsze AM; van den Broek MPH
    Br J Clin Pharmacol; 2020 Aug; 86(8):1567-1574. PubMed ID: 32090369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H; El-Makaty H; Ali Z
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study.
    Larock AS; Mullier F; Sennesael AL; Douxfils J; Devalet B; Chatelain C; Dogné JM; Spinewine A
    Ann Pharmacother; 2014 Oct; 48(10):1258-68. PubMed ID: 24982310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care.
    Ferrat E; Fabre J; Galletout P; Boutin E; Le Breton J; Renard V; Frappé P; Bastuji-Garin S
    Br J Gen Pract; 2021; 71(703):e134-e139. PubMed ID: 33495204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States.
    Baker CL; Dhamane AD; Mardekian J; Dina O; Russ C; Rosenblatt L; Lingohr-Smith M; Menges B; Lin J; Nadkarni A
    Adv Ther; 2019 Jan; 36(1):162-174. PubMed ID: 30499067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey.
    Fuat A; Ako E; Hargroves D; Holden D; Caleyachetty A; Carter M; Harris J; Roberts C; Nzeakor N; Vardar B; Williams H
    J Mark Access Health Policy; 2023; 11(1):2267327. PubMed ID: 37954532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Renal Function on Dosing of Non-Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation.
    Shrestha S; Baser O; Kwong WJ
    Ann Pharmacother; 2018 Feb; 52(2):147-153. PubMed ID: 28856898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study.
    Miyazaki M; Matsuo K; Uchiyama M; Nakamura Y; Sakamoto Y; Misaki M; Tokura K; Jimi S; Okamura K; Adachi S; Yamamoto T; Shirai K; Urata H; Imakyure O
    J Pharm Health Care Sci; 2020; 6():2. PubMed ID: 32071730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Apixaban Prescribing Patterns for Nonvalvular Atrial Fibrillation in Hospitalized Patients.
    Gibson CM; Smith CB; Davis S; Scalese MJ
    Ann Pharmacother; 2018 Jan; 52(1):54-59. PubMed ID: 28799408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants.
    Deitelzweig S; Bruno A; Trocio J; Tate N; Gupta K; Lin J; Lingohr-Smith M
    Curr Med Res Opin; 2016; 32(3):573-82. PubMed ID: 26652179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants.
    Howard M; Lipshutz A; Roess B; Hawes E; Deyo Z; Burkhart JI; Moll S; Shilliday BB
    J Thromb Thrombolysis; 2017 Feb; 43(2):149-156. PubMed ID: 27757787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study).
    Basaran O; Filiz Basaran N; Cekic EG; Altun I; Dogan V; Mert GO; Mert KU; Akin F; Soylu MO; Memic Sancar K; Biteker M
    Clin Appl Thromb Hemost; 2017 May; 23(4):384-391. PubMed ID: 26519049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients.
    Umei M; Kishi M; Sato T; Shindo A; Toyoda M; Yokoyama M; Matsushita M; Ohnishi S; Yamasaki M
    J Arrhythm; 2017 Oct; 33(5):475-482. PubMed ID: 29021853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
    Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
    Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants.
    Baker CL; Dhamane AD; Rajpura J; Mardekian J; Dina O; Russ C; Rosenblatt L; Lingohr-Smith M; Lin J
    Clin Appl Thromb Hemost; 2019; 25():1076029619870249. PubMed ID: 31418293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians.
    Peacock WF; Rafique Z; Singer AJ
    Emerg Med Int; 2016; 2016():1781684. PubMed ID: 27293895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Direct Oral Anticoagulant Dosing and Monitoring in Two Geriatric Outpatient Clinics.
    Howerton MA; Suhrie EM; Gennari AS; Jones N; Ruby CM
    Sr Care Pharm; 2019 Mar; 34(3):192-205. PubMed ID: 31155026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.